Pomegranate compound shows promise against heart failure: Study finds urolithin A improved heart function by up to 80% in experimental models

Urolithin A has emerged as a promising compound in research into heart failure with preserved ejection fraction (HFpEF), with experiments showing improvements of up to 80% in measures of heart function. The compound also helped improve heart muscle relaxation and reduce harmful scarring. However, researchers stressed that the findings are still at an early stage and that clinical trials are needed to determine whether urolithin A can provide similar benefits to people with HFpEF.